首页> 中文期刊> 《当代医学科学(英文)》 >Postsurgical Evaluation of Secondary Nephrogenic Hyperparathyroidism

Postsurgical Evaluation of Secondary Nephrogenic Hyperparathyroidism

         

摘要

Parathyroidectomy is useful for the treatment of secondary hyperparathyroidism(SHPT)caused by chronic renal failure.The following three types of parathyroidectomy can be performed:subtotal parathyroidectomy,total parathyroidectomy and total parathyroidectomy plus autologous transplantation(tPTX+AT).Each of the three types of surgery has advantages and disadvantages.The present study retrospectively analyzed the efficacy of tPTX+AT for the treatment of SHPT over 1 year.Thirty-seven patients who were diagnosed with secondary nephrogenic hyperparathyroidism and treated with tPTX+AT were selected between September 2014 and October 2016 and followed up for 1 year.Their average age was 66.5±46.0 years,and the average time of dialysis was 48.1±8.2 months.The patients1 conditions,including the levels of intact parathyroid hormone(iPTH)and bone metabolism,were compared preoperatively and 1 and 7 days and 1,3,6 and 12 months after surgery.In addition,the postoperative complications,pathological data,SHPT recurrence and prognosis were examined.The results showed that the postoperative level of ostalgia and cutaneous pruritus significantly decreased in the patients.An inspection of the parathyroid tissues during the operation confimied the presence of parathyroid gland hyperplasia with no carcinoma detected?Three patients with hoarseness recovered within 1 month,and 1 patient with unilateral recurrent laryngeal nerve injury improved after 6 months of voice training.Conipared to the preoperative condition,the postoperative serum iPTH,serum calcium and serum phosphate levels were significantly decreased(P0.05).The ALP levels continuously decreased at 3,6 and 12 months(P<0.01).In conclusion,tPTX+AT significantly improves the quality of life and serum biomarker levels of these patients.The convenient surgical removal of the hyperplastic parathyroid gland for postoperative recurrence supports tPTX+AT as the recommended treatment for relevant patients.

著录项

  • 来源
    《当代医学科学(英文)》 |2019年第2期|P.259-264|共6页
  • 作者单位

    [1]Department of Otolaryngology Head and Neck Surgery;

    the 5th Affiliated Hospital of Sun Yat-sen University;

    Zhuhai 519020;

    China;

    [1]Department of Otolaryngology Head and Neck Surgery;

    the 5th Affiliated Hospital of Sun Yat-sen University;

    Zhuhai 519020;

    China;

    [2]Department of Oncology;

    the 5th Affiliated Hospital of Sun Yat-sen University;

    Zhuhai 519020;

    China;

    [1]Department of Otolaryngology Head and Neck Surgery;

    the 5th Affiliated Hospital of Sun Yat-sen University;

    Zhuhai 519020;

    China;

    [1]Department of Otolaryngology Head and Neck Surgery;

    the 5th Affiliated Hospital of Sun Yat-sen University;

    Zhuhai 519020;

    China;

  • 原文格式 PDF
  • 正文语种 CHI
  • 中图分类 医药、卫生;
  • 关键词

    nephrogenic hyperparathyroidism; parathyroidectomy; transplantation; autologous;

    机译:肾源性甲状旁腺功能亢进症;甲状旁腺切除术;自体移植;
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号